Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamos...
Q1 2026
May 13, 2026
FY 2025
Mar 23, 2026
Q4 2025
Q3 2025
Nov 12, 2025
Q2 2025
Aug 14, 2025